This is a preview of subscription content, log in via an institution to check access.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bouchie, A. Companies in footrace to deliver RNAi. Nat Biotechnol 30, 1154–1155 (2012). https://doi.org/10.1038/nbt1212-1154
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1212-1154
- Springer Nature America, Inc.
This article is cited by
-
Small RNA modifications: regulatory molecules and potential applications
Journal of Hematology & Oncology (2023)
-
Alnylam's RNAi therapy targets amyloid disease
Nature Biotechnology (2015)
-
Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice
Molecular Therapy - Nucleic Acids (2013)